Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.

Developments in biological standardization

Volumn 92, Issue , 1998, Pages 127-133

  Haneberg, B ^a   Dalseg, R ^a   Oftung, F ^a   Wedege, E ^a   Hoiby E A ^a   Haugen, I L ^a   Holst, J ^a   Andersen, S R ^a   Aase, A ^a   Meyer Naess, L ^a   Michaelsen, T E ^a   Namork, E ^a   Haaheim, L R ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE;

ADULT; ANIMAL; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; SERUM BACTERICIDAL ACTIVITY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; NEISSERIA MENINGITIDIS;

EID: 0031616667     PISSN: 03015149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)